[Long time survival of the regenerated optic nerve axons in Bcl-2 transgenic mice].
OBJECTIVE
To study if the regenerating axons can be alive till adult and restore function when the optic nerve was crushed at 3 days after birth (P3) in Bcl-2 transgenic mice.


METHODS
It was a experimental study. Optic nerve crush was performed on C57Bl/6J and Bcl-2 transgenic mice at P3, immediately followed by intro vitreous injection of a nerve axon tracer--cholera toxin B subunit conjugated with fluorescein (CTB-F). Mice were sacrificed at day 4, 8, 10, 13, 18 and 24 post operation, the optic nerve and the brain was cryosectioned. Immunofluorescence staining of GAP43 was carried out to evaluate the regenerating axon. Same procedure was used together with immediately MK801 intro vitreous injection, gel foam soaked with NMDA or BDNF put in superior colliculus. Mice were sacrificed on 10 or 13 days post operation. Optic nerve regeneration was evaluated.


RESULTS
The regenerated optic nerve axons reached the targets in the brain at 4 days post operation. But after 10 days, the regenerated axons were retracted. MK801, NMDA and BDNF can prolonged the alive of regenerated axons in the brain targets, but its alive was only lasted 3 more days. It retracted finally on 13 days after surgery.


CONCLUSIONS
Optic nerve can regenerate successfully to reach the targets in the brain when it was crushed on P3 in Bcl-2 transgenic mice, but the regenerated nerve axons can only survive for 10 days when it is retracted from the brain. It is probably because of the failure of the synapse formation at this time.
Liu
Yang
Y
Department of Ophthalmology, Peking University First Hospital, Beijing 100034, China. yl6565@yahoo.com
Yuan
Peng
P
Dong-Feng
Chen
C
D000818:Animals; D001369:Axons / Q000502:physiology*; D005260:Female; D019254:Genes, bcl-2; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009416:Nerve Regeneration; D009900:Optic Nerve / Q000502:physiology*; D020221:Optic Nerve Injuries / Q000628:therapy; D012165:Retinal Ganglion Cells / Q000502:physiology; D014022:Tissue Survival / Q000502:physiology*